Update to CDC's sexually transmitted diseases treatment guidelines, 2006: Fluoroquinolones no longer recommended for treatment of gonococcal infections

Morbidity and Mortality Weekly Report

Volumn 56, Issue 14, 2007, Pages 332-336

  Del Rio, C ^a   Hall, G ^b   Hook III, E W ^c   Holmes, K K ^d   Whittington, W L H ^d   Judson, F N ^e   Yee, E L ^f   Harvey, A B ^f   Kramer, K P ^f   Trees, D L ^f   Ballard, R ^f   Workowski, K A ^f   Newman, L M ^f   Berman, S ^f   Weinstock, H S ^f  

^a EMORY UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; FEMALE; GONORRHEA; HUMAN; MALE; NEISSERIA GONORRHOEAE; PRACTICE GUIDELINE; UNITED STATES;

ANTI-INFECTIVE AGENTS; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; FEMALE; FLUOROQUINOLONES; GONORRHEA; HUMANS; MALE; NEISSERIA GONORRHOEAE; PRACTICE GUIDELINES; UNITED STATES;

EID: 34247145113     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. CDC. Sexually transmitted disease surveillance 2005. Atlanta, GA: US Department of Health and Human Services, CDC; 2006. Available at http://www.cdc.gov/nchstp/dstd/stats_trends/stats_and_trends.htm.
2. CDC. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae - Hawaii and California, 2001. MMWR 2002;51:1041-4.
3. CDC. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men - United States, 2003, and revised recommendations for gonorrhea treatment, 2004. MMWR 2004;53:335-8.
4. CDC. Sexually transmitted diseases treatment guidelines, 2006. MMWR 2006;55(No. RR-11).
5. CDC. Sexually transmitted disease surveillance 2005 supplement: Gonococcal Isolate Surveillance Project (GISP) annual report, 2005. Atlanta, GA: US Department of Health and Human Services, CDC; 2007. Available at http://www.cdc.gov/std/GISP2005/default.htm.
6. Newman L, Moran JS, Workowski KA. Update on the management of gonorrhea in adults in the United States. Clin Infect Dis 2007;44:S84-S101.
7. CDC. Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999. MMWR 2000;49:833-7.
8. Gonococcal Resistance to Antimicrobials Surveillance Programme GRASP) Steering Group. GRASP year 2005 report. London, England: Health Protection Agency; 2006. Available at http://www.hpa.org.uk/infections/topics_az/ hiv_and_sti/sti-gonorrhoea/publications/grasp_2005_annual_report.pdf.
9. CDC. Sexually transmitted disease surveillance 2004 supplement: Gonococcal Isolate Surveillance Project (GISP) annual report, 2004. Atlanta, GA: US Department of Health and Human Services, CDC; 2005. Available at http://www.cdc.gov/std/GISP2004/default.htm.
10. Dicker LW, Mosure DJ, Steece R, Stone KM. Testing for sexually transmitted diseases in U.S. public health laboratories in 2004. Sex Transm Dis 2007;34:41-6.